These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Sulacillin (a combination of ampicillin and sulbactam)--a new combined drug form for treatment of bacterial infections].
    Author: Bogomolova NS, Belova ON, Vasil'ev MM, Novikova IuA, Pankova GF, Perepanova TS, Sokolova VI, Strachunskiĭ LS, Shandurenko IN, Pozdniakova VP.
    Journal: Antibiot Khimioter; 1995 Jun; 40(6):43-8. PubMed ID: 8593095.
    Abstract:
    The results of the cooperated clinical trial of sulacillin, a formulation including sodium ampicillin and sulbactam (2:1), are presented. The trial was carried out in different hospitals of Moscow and Smolensk. Rapid development of the favourable time course and recovery were stated in 93.7 per cent of the cases with upper and lower respiratory tract infections, urinary and biliferous tract infections, infections of the skin and soft tissues, gynecological infections and severe suppurative complications after surgical operations. Sulacillin is useful in the empirical therapy of purulent inflammatory diseases before the pathogen isolation and identification.
    [Abstract] [Full Text] [Related] [New Search]